메뉴 건너뛰기




Volumn 37, Issue 3, 2011, Pages 235-239

In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: Proposition of zone diameter breakpoints

Author keywords

Breakpoints; Ceftobiprole; In vitro activity; New cephalosporin

Indexed keywords

AMPICILLIN; CEFEPIME; CEFTOBIPROLE; METICILLIN; PENICILLIN G;

EID: 79951949188     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.11.035     Document Type: Article
Times cited : (9)

References (15)
  • 1
    • 0035115180 scopus 로고    scopus 로고
    • In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci
    • DOI 10.1128/AAC.45.3.825-836.2001
    • P. Hebeisen, I. Heinze-Krauss, P. Angehrn, P. Hohl, M.G. Page, and R.L. Then In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci Antimicrob Agents Chemother 45 2001 825 836 (Pubitemid 32182033)
    • (2001) Antimicrobial Agents and Chemotherapy , vol.45 , Issue.3 , pp. 825-836
    • Hebeisen, P.1    Heinze-Krauss, I.2    Angehrn, P.3    Hohl, P.4    Page, M.G.P.5    Then, R.L.6
  • 2
  • 3
    • 25844470484 scopus 로고    scopus 로고
    • Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin
    • DOI 10.1128/AAC.49.10.4210-4219.2005
    • T. Bogdanovich, L.M. Ednie, S. Shapiro, and P.C. Appelbaum Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin Antimicrob Agents Chemother 49 2005 4210 4219 (Pubitemid 41400966)
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , Issue.10 , pp. 4210-4219
    • Bogdanovich, T.1    Ednie, L.M.2    Shapiro, S.3    Appelbaum, P.C.4
  • 5
    • 73849107006 scopus 로고    scopus 로고
    • In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa
    • J. Fernandez, J.J. Hilliard, D. Abbanat, W. Zhang, J.L. Melton, and C.M. Santoro In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa Antimicrob Agents Chemother 54 2010 116 125
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 116-125
    • Fernandez, J.1    Hilliard, J.J.2    Abbanat, D.3    Zhang, W.4    Melton, J.L.5    Santoro, C.M.6
  • 6
    • 14744278669 scopus 로고    scopus 로고
    • Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus
    • DOI 10.1128/AAC.49.3.884-888.2005
    • H.F. Chambers Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus Antimicrob Agents Chemother 49 2005 884 888 (Pubitemid 40327700)
    • (2005) Antimicrobial Agents and Chemotherapy , vol.49 , Issue.3 , pp. 884-888
    • Chambers, H.F.1
  • 7
    • 0036136841 scopus 로고    scopus 로고
    • BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis
    • DOI 10.1128/AAC.46.1.171-177.2002
    • J.M. Entenza, P. Hohl, I. Heinze-Krauss, M.P. Glauser, and P. Moreillon BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis Antimicrob Agents Chemother 46 2002 171 177 (Pubitemid 34031620)
    • (2002) Antimicrobial Agents and Chemotherapy , vol.46 , Issue.1 , pp. 171-177
    • Entenza, J.M.1    Hohl, P.2    Heinze-Krauss, I.3    Glauser, M.P.4    Moreillon, P.5
  • 8
    • 70350686593 scopus 로고    scopus 로고
    • Ceftobiprole: A new cephalosporin for the treatment of skin and skin structure infections
    • P.L. Schirmer, and S.C. Deresinski Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections Expert Rev Anti Infect Ther 7 2009 777 791
    • (2009) Expert Rev Anti Infect Ther , vol.7 , pp. 777-791
    • Schirmer, P.L.1    Deresinski, S.C.2
  • 10
    • 79951952461 scopus 로고    scopus 로고
    • Comité de l'Antibiogramme de la Société Française de Microbiologie Paris, France: Société Française de Microbiologie [accessed4January2011]
    • Comité de l'Antibiogramme de la Société Franaise de Microbiologie. Recommandations 2010. Paris, France: Société Franaise de Microbiologie. http://www.sfm-microbiologie.org [accessed 4 January 2011].
    • Recommandations 2010
  • 11
    • 54249114022 scopus 로고    scopus 로고
    • European Committee on Antimicrobial Susceptibility Testing (EUCAST) Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID) [accessed4January2011]
    • European Committee on Antimicrobial Susceptibility Testing (EUCAST). Clinical breakpoints. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID); 2009. http://www.eucast.org [accessed 4 January 2011].
    • (2009) Clinical Breakpoints
  • 12
    • 79951948954 scopus 로고    scopus 로고
    • Antimicrobial susceptibility testing: Practical implementation of the EUCAST breakpoints and methods
    • 10-13 April 2010, Vienna, Austria. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Educational workshop 8
    • Kahlmeter G, Brown D. Antimicrobial susceptibility testing: practical implementation of the EUCAST breakpoints and methods. In: European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); 10-13 April 2010, Vienna, Austria. Basel, Switzerland: European Society of Clinical Microbiology and Infectious Diseases (ESCMID); 2010. Educational workshop 8.
    • (2010) European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
    • Kahlmeter, G.1    Brown, D.2
  • 13
    • 0036924109 scopus 로고    scopus 로고
    • In vitro evaluation of BAL9141, a novel parental cephalosporin active against oxacillin-resistant staphylococci
    • DOI 10.1093/jac/dkf249
    • R.N. Jones, L.M. Deshpande, A.H. Mutnick, and D.J. Biedenbach In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci J Antimicrob Chemother 50 2002 915 932 (Pubitemid 36032813)
    • (2002) Journal of Antimicrobial Chemotherapy , vol.50 , Issue.6 , pp. 915-932
    • Jones, R.N.1    Deshpande, L.M.2    Mutnick, A.H.3    Biedenbach, D.J.4
  • 14
    • 40049097830 scopus 로고    scopus 로고
    • In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin
    • DOI 10.1093/jac/dkm492
    • C.M. Pillar, M.K. Aranza, D. Shah, and D.F. Sahm In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin J Antimicrob Chemother 61 2008 595 602 (Pubitemid 351321133)
    • (2008) Journal of Antimicrobial Chemotherapy , vol.61 , Issue.3 , pp. 595-602
    • Pillar, C.M.1    Aranza, M.K.2    Shah, D.3    Sahm, D.F.4
  • 15
    • 77957335538 scopus 로고    scopus 로고
    • Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa using cefepime, ceftazidime, or ceftobiprole
    • A.M. Queenan, W. Shang, K. Bush, and R.K. Flamm Differential selection of single-step AmpC or efflux mutants of Pseudomonas aeruginosa using cefepime, ceftazidime, or ceftobiprole Antimicrob Agents Chemother 54 2010 4092 4097
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 4092-4097
    • Queenan, A.M.1    Shang, W.2    Bush, K.3    Flamm, R.K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.